Moreover, polymorphisms in a number of complement genes such as, CFH, C3, CFB and C2, have been shown to be associated with AMD12–14 suggesting that the complement system, in particular the alternative pathway, may be dysregulated in AMD patients. The gene discussed is C3; the disease is age-related macular degeneration.